1. Home
  2. CGTX

as 09-08-2025 3:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Founded: 2007 Country:
United States
United States
Employees: N/A City: PITTSBURGH
Market Cap: 53.4M IPO Year: 2021
Target Price: $2.83 AVG Volume (30 days): 12.4M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.63 EPS Growth: N/A
52 Week Low/High: $0.22 - $3.83 Next Earning Date: 08-07-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

CGTX Daily Stock ML Predictions

Share on Social Networks: